Latest News - Stroke & Cerebrovascular

Wednesday, September 19, 2018

Exercise May Reduce Stroke Severity

In a study published in the online issue of Neurology (September 19, 2018), researchers have shown that people who exercise have lower stroke severity if and when they do experience stroke. In th…

Read the full story

Friday, September 07, 2018

Neuromodulation Effective for Dysphagia in Patients Who Experience Stroke and Reduces Length of Hospital Stay

Despite improvements in stroke care and patient outcomes, approximately 16% of patients who experience a stroke have a tracheostomy and ventilatory support. Dysphagia can significantly delay removal o…

Read the full story

Tuesday, September 04, 2018

New 7th Generation Mechanical Thrombectomy Device Launched by Penumbra

The Penumbra JET 7 and Penumbra JET D reperfusion catheters are no commercially available in the US, manufactured by and available from Penumbra (Alameda, CA). Both catheters are powered by the Penumb…

Read the full story

Thursday, August 16, 2018

Intrathecal Baclofen More Effective Than Oral Medication for Treating Pain in Patients With Poststroke Spasticity

Results from the SISTERS trial (NCT01032239) show that intrathecal administration (ITB Therapy; Medtronic, Dublin, Ireland) of baclofen (Lioresal Intrathecal; Saol Therapeutics, Roswell, GA) is a more…

Read the full story

Wednesday, August 01, 2018

First Patient Enrolled in Phase 3 Study of Athersys’ Stem Cell Treatment for Patients who Experienced Ischemic Stroke

The first patient has been enrolled in a phase 3 study, MASTERS-2 (NCT03545607), which is a pivotal study that has received special protocol assessment, fast-track designation, and regenerative medici…

Read the full story

Monday, July 30, 2018

Breaching the Blood-Brain Barrier: A Potential New Treatment Modality

In a small, yet groundbreaking, clinical trial, MR-guided focused ultrasound (MRgFUS) (ExablateNeuro; Insightec, Miami FL) was used to open the blood-brain barrier (BBB) safely in 5 persons with mild-…

Read the full story

Monday, July 30, 2018

Aggressive Treatment of Hypertension Promotes Healthy Brains and Hearts

Aggressive lowering of systolic blood pressure (BP) reduces the risk of mild cognitive impairment (MCI) and combined MCI and dementia. In the SPRINT trial (NCT01206062), 2 strategies for managing high…

Read the full story

Thursday, July 26, 2018

Every Minute Counts in Treating Stroke

The Society of NeuroInterventional Surgery (SNIS) announced findings from a study using a Markov model of lifetime quality-adjusted life years (QALYs) in patients treated with endovascular thrombectom…

Read the full story

Wednesday, July 25, 2018

First Patients Treated With Next-Generation Embotrap II Stent Retriever

Cerenovus, part of the Johnson & Johnson Medical Devices Companies, announced the launch of its Embotrap II revascularization device at the Society of NeuroInterventional Surgery's 15th Annual…

Read the full story

Tuesday, July 17, 2018

Stryker's Surpass Streamline Flow Diverter for Treating Intracranial Aneurysms Receives Approval

Stryker announced that the Food and Drug Administration (FDA) has granted premarket approval for the Surpass Streamline flow diverter to treat unruptured large and giant wide-neck intracranial aneurys…

Read the full story

Wednesday, June 06, 2018

Black and Hispanic People May Be More Likely to Have a Second Hemorrhagic Stroke than Whites

Results from a study published online in the journal Neurology suggest that black and Hispanic people may be more likely to have a second hemorrhagic stroke compared to white people who have had a hem…

Read the full story

Thursday, May 31, 2018

FDA Grants Clearance for Fully Implantable Wireless Intracranial Pressure Sensor

The AURA intracranial pressure (ICP) monitoring system (Branchpoint Technologies, Irvine, CA) has been granted clearance by the Food and Drug Administration (FDA). This first of kind system is fully i…

Read the full story

Tuesday, May 22, 2018

FDA Clears Next-Generation Stent Retriever to Treat Ischemic Stroke

Cerenovus, part of the Johnson & Johnson Medical Devices Companies, announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Embotrap II revasculariza…

Read the full story

Tuesday, May 15, 2018

Poor Blood-Pressure Control Related to More Lacunar Strokes at Earlier Age

While elevated blood pressure is a well-established risk factor for stroke, there has been debate regarding the roll of elevated blood pressure in lacunar stroke with some studies suggesting that hype…

Read the full story

Wednesday, May 09, 2018

FDA Issues Recommendation on Neurovascular Stents Used for Stent-Assisted Coiling of Unruptured Brain Aneurysm

The US Food and Drug Administration (FDA) has issued a letter to health care providers that gives recommendations on patient selection and use of neurovascular stents for stent-assisted coiling (SAC) …

Read the full story
Load More